Advances in Electrode Technology Could Mean Less Invasive Surgery for Neurosurgery Patients
Join us in recognizing Alzheimer’s and Brain Awareness Month this June.
An estimated 5.8 million Americans age 65 and older are living with Alzheimer's dementia, and almost two-thirds of Americans with Alzheimer's are women. As the number of older Americans increases, it is likely that the number of new cases of Alzheimer's will also rise.
In fact, studies have shown that, without medical breakthroughs to prevent, slow or cure Alzheimer’s disease, the number of people age 65 and older with Alzheimer’s dementia may grow to 13.8 million by 2050 with the total cost for patient care projected to exceed $1.1 trillion.
During Alzheimer’s and Brain Awareness Month, NeuroOne takes the opportunity to voice its support for the Alzheimer's Association and its campaign to “go purple” in raising awareness about Alzheimer's and other neurological conditions. Other brain disorders include epilepsy, Parkinson's and other movement disorders, stroke, and transient ischemic attack.
This is also an excellent time to promote advances in technology designed to enhance neurosurgery and patient outcomes in a cost-efficient manner.
Exciting Advances in Neurology Technology
NeuroOne’s Evo™ Cortical Electrodes (“Evo”) are the first FDA-cleared, thin film flexible electrodes designed to record brain activity and stimulate brain tissue for up to 30 days. Evo is designed to be less invasive than current technology, to improve the surgical experience and to enhance mapping capabilities to help people suffering from neurological disorders.
Neurosurgeons that perform epilepsy surgery predominantly use sEEG electrodes because they can be placed minimally invasively through a stereotactic procedure. In several clinical scenarios, implanting cortical electrodes and sEEG may potentially provide a more complete map of the brain by obtaining recordings from the surface and deep structures of the cortex. Physicians also recognize the potential of thin film electrodes and Evo for applications with Parkinson’s disease, dystonia, essential tremors, and pain management for failed back surgery syndrome.
Contact us to learn more about our Evo Electrode.